| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/31/2002 | EP1226828A1 Medicinal compositions for inhibiting gvhd |
| 07/31/2002 | EP1226441A1 Protein tyrosine kinase receptor polynucleotides, polypeptides, and antibodies |
| 07/31/2002 | EP1226435A1 Axor35, a g-protein coupled receptor |
| 07/31/2002 | EP1226279A1 Modulation of neuroendocrine differentiation by protein 25.1 |
| 07/31/2002 | EP1226267A1 Process for producing a product containing antihypertensive tripeptides |
| 07/31/2002 | EP1226263A1 Invasive bacterial vectors for expressing alphavirus replicons |
| 07/31/2002 | EP1226254A2 Virulence genes, proteins, and their use |
| 07/31/2002 | EP1226249A2 Follistatin-related protein zfsta4 |
| 07/31/2002 | EP1226248A1 Cloning, expression and characterisation of a gene expressed in tumour cells and involved in the regulation of the immune response |
| 07/31/2002 | EP1226247A1 Human gpr27-like g-protein coupled receptor polypeptide and polynucleotide sequences |
| 07/31/2002 | EP1226246A1 Polypeptides with expanded primary signalling motifs |
| 07/31/2002 | EP1226245A2 Hybrid adaptor receptors |
| 07/31/2002 | EP1226244A2 Polypeptides with non-natural primary signalling motifs |
| 07/31/2002 | EP1226243A2 Nucleic acid molecules derived from rat brain and programmed cell death models |
| 07/31/2002 | EP1226241A1 A general method for optimizing the expression of heterologous proteins |
| 07/31/2002 | EP1226237A2 Method of identifying inhibitors of cdc25 |
| 07/31/2002 | EP1226235A2 Cell constructs that are suitable for immunotherapy, the production and the use thereof |
| 07/31/2002 | EP1226231A1 19 human secreted proteins |
| 07/31/2002 | EP1226230A1 Lactobacillus helveticus producing antihypertensive di- and tripeptides |
| 07/31/2002 | EP1226212A1 Polymeric composition for solubilizing poorly water soluble drugs and process for the preparation thereof |
| 07/31/2002 | EP1226178A1 Recombinant fusion molecules |
| 07/31/2002 | EP1226175A1 Death domain-containing receptor polynucleotides, polypeptides, and antibodies |
| 07/31/2002 | EP1226173A1 Single-chain antagonist polypeptides |
| 07/31/2002 | EP1226172A1 Compounds, antibodies and methods for treating, preventing or diagnosing tumour metastasis |
| 07/31/2002 | EP1226170A2 Human proteins and polynucleotides encoding the same |
| 07/31/2002 | EP1226168A1 Ligand activated transcriptional regulator proteins |
| 07/31/2002 | EP1226167A1 Modified peptides and peptidomimetics for use in immunotherapy |
| 07/31/2002 | EP1226164A1 Human metabotropic glutamate receptor |
| 07/31/2002 | EP1226163A2 Nucleotide sequence of the shrimp white spot syndrome bacilliform virus (wsbv), systems containing this sequence and detection kits |
| 07/31/2002 | EP1226162A1 Novel molecules of the card-related protein family and uses thereof |
| 07/31/2002 | EP1226160A2 Novel antiarrhythmic peptides |
| 07/31/2002 | EP1226159A1 Substituted dipeptides having nos inhibiting activity |
| 07/31/2002 | EP1226154A1 Estradiol conjugates and uses thereof |
| 07/31/2002 | EP1226152A2 Regulation of gene expression by neuroleptic agents |
| 07/31/2002 | EP1226150A1 Tadg-15: an extracellular serine protease overexpressed in carcinomas |
| 07/31/2002 | EP1226149A1 Compositions and methods for identifying polypeptides and nucleic acid molecules |
| 07/31/2002 | EP1226139A2 Cyclized amide derivatives for treating or preventing neuronal damage |
| 07/31/2002 | EP1226115A1 Novel carbamates and ureas |
| 07/31/2002 | EP1226109A2 Phenyl amine carboxylic acid compounds and compositions for delivering active agents |
| 07/31/2002 | EP1226104A1 Phenoxy carboxylic acid compounds and compositions for delivering active agents |
| 07/31/2002 | EP1225922A1 Selective toxin expression in angiogenic endothelial cells |
| 07/31/2002 | EP1225921A1 TECHNIQUES AND COMPOSITIONS FOR TREATING CARDIOVASCULAR DISEASE BY i IN VIVO /i GENE DELIVERY |
| 07/31/2002 | EP1225919A1 Treatment of cancer |
| 07/31/2002 | EP1225918A2 Conjugates useful in the treatment of prostate cancer |
| 07/31/2002 | EP1225915A2 Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies |
| 07/31/2002 | EP1225914A2 A method to improve protective immunity induced by polynucleotide vaccines |
| 07/31/2002 | EP1225913A1 Use of nitric oxide for the treatment of airway constriction |
| 07/31/2002 | EP1225911A1 Methods of treating or preventing cell, tissue, and organ damage using human myeloid progenitor inhibitory factor-1 (mpif-1) |
| 07/31/2002 | EP1225910A2 MODULATION OF eNOS ACTIVITY AND THERAPEUTIC USES THEREOF |
| 07/31/2002 | EP1225909A2 Fibroblast growth factor-5 (fgf-5) is a tumor associated t-cell antigen |
| 07/31/2002 | EP1225908A2 Therapeutic applications of flint polypeptides |
| 07/31/2002 | EP1225901A2 Uses and compositions for treating platelet-related disorders using anagrelide |
| 07/31/2002 | EP1225899A2 METHOD FOR THE TREATMENT OR PREVENTION OF i FLAVIVIRIDAE /i VIRAL INFECTION USING NUCLEOSIDE ANALOGUES |
| 07/31/2002 | EP1225814A1 Fibrous-liponutritional complexes and compositions containing them |
| 07/31/2002 | EP1049490B1 Method for inhibiting cd95-independent apoptosis in aids |
| 07/31/2002 | EP0920630B1 Prion binding proteins and uses thereof |
| 07/31/2002 | EP0914095B1 Method for fabricating polymer-based controlled-release devices |
| 07/31/2002 | EP0793418B1 Germicidal detergent-iodine compositions including polyvinyl pyrrolidone and compatible nonionic surfactant complexors |
| 07/31/2002 | EP0790834B1 Composition containing pooled transferrins as an active principle for the induction of immune tolerance against antigens |
| 07/31/2002 | EP0764152B1 Substituted indolylmethylene-oxindole analogues as tyrosine kinase inhibitors |
| 07/31/2002 | EP0744955B1 Cyclic heptapeptide anti-inflammatory agent |
| 07/31/2002 | EP0698109B1 Gene transfer into pancreatic epithelial cells |
| 07/31/2002 | EP0583356B1 A method for treating infectious respiratory diseases |
| 07/31/2002 | CN1361865A Catalytic anti-factor VIII allo-antibodies |
| 07/31/2002 | CN1361825A Novel antifungal agents and fungicides method for the production thereof and their use |
| 07/31/2002 | CN1361823A Global regulators of bacterial pathogenic genes, bacterial autoinducer inactivation protein, as targets for engineering disease resistance |
| 07/31/2002 | CN1361822A Reg-binding protein |
| 07/31/2002 | CN1361821A Instant formulations of enzymes, used for animal feed |
| 07/31/2002 | CN1361793A Expression and export of interferon-alpha proteins as Fc fusion proteins |
| 07/31/2002 | CN1361792A Cyclic peptide derivatives as inhibitors of integrin alpha/beta |
| 07/31/2002 | CN1361791A Process for deacylation of lipodepsipeptides |
| 07/31/2002 | CN1361790A Amine-modified pseudomycin compounds |
| 07/31/2002 | CN1361789A Rapid dehydration of proteins |
| 07/31/2002 | CN1361698A Prolyl endopeptidase inhibitor |
| 07/31/2002 | CN1361695A Analgesic from snake venom |
| 07/31/2002 | CN1361684A Biodegradable poly (alkylene oxide)-poly cp-dioxanone) block copolymer soluble in organic solvents, and drug delivery composition comprising same |
| 07/31/2002 | CN1361677A Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same |
| 07/31/2002 | CN1361286A Construction and application of recombinant probiotics strain to express human endothelial cell inhibin |
| 07/31/2002 | CN1361281A New polypeptide Beta lactamase 11.66 and polynucleotides encoding this polypeptide |
| 07/31/2002 | CN1361280A New plasmin and its coding sequence and use |
| 07/31/2002 | CN1361279A Lichenized bacillus L-25 keratinase and its encoding DNA |
| 07/31/2002 | CN1361277A New polypeptide human ATP dependent serine proteinase 9.13 and polynucleotides encoding this polypeptide |
| 07/31/2002 | CN1361276A New polypeptide human cysteine proteinase 10.89 and polynucleotides encoding this polypeptide |
| 07/31/2002 | CN1361275A New polypeptide human signalase I9.02 and polynucleotides encoding this polypeptide |
| 07/31/2002 | CN1361274A New polypeptide human glycosylhydrolase 10.78 and polynucleotides encoding this polypeptide |
| 07/31/2002 | CN1361273A New polypeptide human protein tyrosine phosphatase 15.62 and polynucleotides encoding this polypeptide |
| 07/31/2002 | CN1361272A New polypeptide soluble epoxide hydrolase 10.78 and polynucleotides encoding this polypeptide |
| 07/31/2002 | CN1361271A New polypeptide ATP dependent uncoiling enzyme protein 10.01 and polynucleotides encoding this polypeptide |
| 07/31/2002 | CN1361270A New polypeptide human dihydropyrimidinase associated protein-1 (DRP-1) 8.8 and polynucleotides encoding this polypeptide |
| 07/31/2002 | CN1361269A New polypeptide human RNA unwinding enzyme 9.13 and polynucleotides encoding this polypeptide |
| 07/31/2002 | CN1361267A New polypeptide human hexokinase protein 11.66 and polynucleotides encodin this polypeptide |
| 07/31/2002 | CN1361266A New polypeptide human glucokinase 31.35 and polynucleotides encoding this polypeptide |
| 07/31/2002 | CN1361265A New polypeptide human focal adhesion kinase (FAK) 10.01 and polynucleotides encoding this polypeptide |
| 07/31/2002 | CN1361264A New polypeptide human inhibitor molecule I kappa B kinase 37.40 and polynucleotides encoding this polypeptide |
| 07/31/2002 | CN1361263A New polypeptide thymidine kinase 9.68 and polynucleotides encoding this polypeptide |
| 07/31/2002 | CN1361262A New polypeptide hypoxanthine phosphoribosyl pyrophosphate transferase 32.34 and polynucleotides encoding this polypeptide |
| 07/31/2002 | CN1361261A New polypeptide phosphoenolpyruvate dependent sugar phosphotransferase 14.19 and polynucleotides encoding this polypeptide |
| 07/31/2002 | CN1361260A New polypeptide histone acetyl transferase 21.67 and polynucleotides encoding this polypeptide |
| 07/31/2002 | CN1361259A New polypeptide receptor tyrosine kinase 23.87 and polynucleotides encoding this polypeptide |
| 07/31/2002 | CN1361258A New polypeptide human dihydropyridine dicarboxylic acid dehydrogenase 9.02 and polynucleotides encoding this polypeptide |